ABIVAX Société Anonyme (EPA:ABVX)
122.90
+0.30 (0.24%)
Jul 10, 2026, 5:35 PM CET
ABIVAX Société Anonyme Employees
ABIVAX Société Anonyme had 80 employees as of March 31, 2026. The number of employees increased by 11 or 15.94% since the number was last reported on December 31, 2025.
Employees
80
Change
11
Growth
15.94%
Revenue / Employee
€61,500
Profits / Employee
€4,152,500
Market Cap
10.57B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 80 | 11 | 15.94% | 80 | 0 |
| Dec 31, 2025 | 69 | 0 | - | 69 | 0 |
| Dec 31, 2024 | 69 | 8 | 13.11% | 69 | 0 |
| Dec 31, 2023 | 61 | 37 | 154.17% | 61 | 0 |
| Dec 31, 2022 | 24 | 0 | - | 24 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 674 |
| Cellectis | 229 |
| Genfit | 188 |
| Innate Pharma | 164 |
| DBV Technologies | 161 |
| MedinCell | 145 |
| Transgene | 145 |
| Nanobiotix | 100 |
ABIVAX Société Anonyme News
- 15 hours ago - Abivax $920 million cash haul lets it prepare for solo U.S. launch instead of relying on a buyer, CEO tells CNBC - CNBC
- 1 day ago - Abivax price target raised to $175 from $165 at Piper Sandler - TheFly
- 3 days ago - Abivax: Wall Street Catches Up to the Data - MarketBeat
- 4 days ago - Abivax Announces Closing of $920 Million Public Offering - GlobeNewsWire
- 7 days ago - European Markets Rise to Record Highs Amid Optimism; Abivax SA (ABVX) Surges - GuruFocus
- 8 days ago - Abivax price target raised to $155 from $135 at Truist - TheFly
- 8 days ago - Abivax Shares Continue Climbing After Biotech Firm Moves to Bolster Balance Sheet - WSJ
- 8 days ago - Abivax Announces Full Exercise of Underwriters' Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M) - GlobeNewsWire